Ludovic Lecointre

CEO & Co-founder at ICONEUS

Ludovic Lecointre has extensive work experience in the pharmaceutical industry. Ludovic started their career at Bristol-Myers Squibb in 1989 as a Team Manager in Analytical Development. Ludovic worked there until 1994 and then moved onto BOUCHARA RECORDATI as the Head of Analytical Development. In 1996, they joined Jouveinal in the same role and then transitioned to Parke Davis. At Parke Davis, they continued to excel in Analytical Development until 2000 when they joined Pfizer as the Head of Clinical Formulation Development. After their time at Pfizer, they worked as a Freelance Expert at ANSM for Drug MAA files from 2009 to 2015. Finally, Ludovic Lecointre owned and managed the Pharmacie de St Rémy from 2004 to 2016 before becoming the CEO and Co-founder of ICONEUS in 2016.

Ludovic Lecointre completed their education at several institutions. In 1981, they earned a Pharm D. degree in pharmacy, chemistry, and drug delivery from the University of pharmacy. Ludovic then pursued a Master's degree in Spectrochemistry at Pierre et Marie Curie from 1986 to 1987. In 1987, they completed a DESS degree in Quality control of drugs at the University of pharmacy. Later, in 2016, Ludovic attended HEC Paris for the HEC Challenge + program in Business/Start-up. Finally, there is no specified information about their education at emlyon business school.

Location

Paris, France

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices


ICONEUS

Real-time portable functional ultrasound neuro-imaging ICONEUS is introducing functional ultrasound neuro imaging: a breakthrough imaging modality for brain activity monitoring based on blood flow imaging with ultra-high sensitivity. For preclinical research, the portability and high versatility of our technology enables the study of brain activity at unprecedented scales and in a large variety of subject states: awake, behaving, freely-moving, resting-state and asleep conditions. Our technology can be easily combined with other complementary modalities such as eeg headstage or optogenetics which are inherently difficult to combine with fmri. Iconeus also offers key applications such as functional connectivity assessment between brain structures (connectomics) or stroke 4D monitoring. Building on years of preclinical expertise and research, we’re now investing and supporting exciting new clinical applications, using our Iconeus One CR functional ultrasound system dedicated to clinical research.


Headquarters

Paris, France

Employees

11-50

Links